Terns Pharmaceuticals (TERN) Current Leases (2022 - 2023)
Terns Pharmaceuticals (TERN) has disclosed Current Leases for 2 consecutive years, with $707000.0 as the latest value for Q3 2023.
- For the quarter ending Q3 2023, Current Leases rose 6.32% year-over-year to $707000.0, compared with a TTM value of $707000.0 through Sep 2023, up 6.32%, and an annual FY2022 reading of $661000.0, changed N/A over the prior year.
- Current Leases was $707000.0 for Q3 2023 at Terns Pharmaceuticals, up from $653000.0 in the prior quarter.
- Across five years, Current Leases topped out at $707000.0 in Q3 2023 and bottomed at $584000.0 in Q1 2022.